164 related articles for article (PubMed ID: 37560217)
1. Peptidyl arginine deiminase inhibition alleviates angiotensin II-induced fibrosis.
Ijichi T; Sundararaman N; Martin TG; Pandey R; Koronyo E; Kirk JA; Marbán E; Van Eyk JE; Fert-Bober J
Am J Transl Res; 2023; 15(7):4558-4572. PubMed ID: 37560217
[TBL] [Abstract][Full Text] [Related]
2. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
Front Immunol; 2021; 12():716250. PubMed ID: 34737738
[TBL] [Abstract][Full Text] [Related]
3. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
Mondal S; Thompson PR
Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
[TBL] [Abstract][Full Text] [Related]
5. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
[TBL] [Abstract][Full Text] [Related]
7. N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.
Willis VC; Gizinski AM; Banda NK; Causey CP; Knuckley B; Cordova KN; Luo Y; Levitt B; Glogowska M; Chandra P; Kulik L; Robinson WH; Arend WP; Thompson PR; Holers VM
J Immunol; 2011 Apr; 186(7):4396-404. PubMed ID: 21346230
[TBL] [Abstract][Full Text] [Related]
8. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
[TBL] [Abstract][Full Text] [Related]
9. Treatment of human cardiac fibroblasts with the protein arginine deiminase inhibitor BB-Cl-amidine activates the Nrf2/HO-1 signaling pathway.
Stachowicz A; Sadiq A; Walker B; Sundararaman N; Fert-Bober J
Biomed Pharmacother; 2023 Nov; 167():115443. PubMed ID: 37703660
[TBL] [Abstract][Full Text] [Related]
10. Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer.
Witalison EE; Cui X; Causey CP; Thompson PR; Hofseth LJ
Oncotarget; 2015 Nov; 6(34):36053-62. PubMed ID: 26440311
[TBL] [Abstract][Full Text] [Related]
11. Current knowledge into the role of the peptidylarginine deiminase (PAD) enzyme family in cardiovascular disease.
Al-U'datt DGF; Allen BG; Hiram R; Alrabadi N
Eur J Pharmacol; 2021 Jan; 891():173765. PubMed ID: 33249073
[TBL] [Abstract][Full Text] [Related]
12. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
13. Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat.
Dang Z; Su S; Jin G; Nan X; Ma L; Li Z; Lu D; Ge R
J Ethnopharmacol; 2020 Mar; 250():112470. PubMed ID: 31862407
[TBL] [Abstract][Full Text] [Related]
14. Peptidyl arginine deiminase inhibition suppresses arthritis via decreased protein citrullination in joints and serum with the downregulation of interleukin-6.
Kawaguchi H; Matsumoto I; Osada A; Kurata I; Ebe H; Tanaka Y; Inoue A; Umeda N; Kondo Y; Tsuboi H; Ishigami A; Sumida T
Mod Rheumatol; 2019 Nov; 29(6):964-969. PubMed ID: 30285515
[No Abstract] [Full Text] [Related]
15. The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest.
Cui X; Witalison EE; Chumanevich AP; Chumanevich AA; Poudyal D; Subramanian V; Schetter AJ; Harris CC; Thompson PR; Hofseth LJ
PLoS One; 2013; 8(1):e53791. PubMed ID: 23308284
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of peptidyl arginine deiminase-4 protects against myocardial infarction induced cardiac dysfunction.
Du M; Yang W; Schmull S; Gu J; Xue S
Int Immunopharmacol; 2020 Jan; 78():106055. PubMed ID: 31816575
[TBL] [Abstract][Full Text] [Related]
17. The investigation of cytotoxic and apoptotic activity of Cl-amidine on the human U-87 MG glioma cell line.
Öğüten PN; Engür Öztürk S; Dikmen M
Medicine (Baltimore); 2024 Feb; 103(8):e37015. PubMed ID: 38394536
[TBL] [Abstract][Full Text] [Related]
18. Chronic administration of Cl-amidine, a pan-peptidylarginine deiminase inhibitor, does not reverse bone loss in two different murine models of osteoporosis.
Vargas-Muñoz VM; Martínez-Martínez A; Muñoz-Islas E; Ramírez-Rosas MB; Acosta-González RI; Jiménez-Andrade JM
Drug Dev Res; 2020 Feb; 81(1):93-101. PubMed ID: 31633211
[TBL] [Abstract][Full Text] [Related]
19. Allopurinol attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction.
Jia N; Dong P; Ye Y; Qian C; Dai Q
Cardiovasc Ther; 2012 Apr; 30(2):117-23. PubMed ID: 20973927
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]